Cargando…
X-box binding protein 1: A new metabolic mediator and drug target of metformin?
Accumulating evidence has demonstrated that metformin improved hypertriglyceridemia. The present study aim to investigate the molecular mechanism by which metformin improves hypertriglyceridemia via regulation of diacylglycerol O-acyltransferase 2 (DGAT2) and X-box binding protein 1 (XBP1) in the li...
Autores principales: | Lou, Kai, Sun, Pei, Zhang, Chunxue, Jiang, Qiang, Pang, Shuguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9691898/ https://www.ncbi.nlm.nih.gov/pubmed/36438823 http://dx.doi.org/10.3389/fphar.2022.1013218 |
Ejemplares similares
-
Constitutive Androstane Receptor-Mediated Inhibition of Metformin on Phase II Metabolic Enzyme SULT2A1
por: Hu, Xiaowen, et al.
Publicado: (2021) -
Progress of potential drugs targeted in lipid metabolism research
por: Liang, Kai, et al.
Publicado: (2022) -
Combined Metabolic Targeting With Metformin and the NSAIDs Diflunisal and Diclofenac Induces Apoptosis in Acute Myeloid Leukemia Cells
por: Renner, Kathrin, et al.
Publicado: (2018) -
The Role of Forkhead Box Family in Bone Metabolism and Diseases
por: Xu, Jianxiang, et al.
Publicado: (2022) -
Natural Products Targeting Liver X Receptors or Farnesoid X Receptor
por: She, Jianglian, et al.
Publicado: (2022)